BACKGROUND:
Voriconazole (VRZ) is a second-generation triazole antifungal agent with broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily indicated for treating invasive aspergillosis. The most commonly used dose for adults is 4 mg/kg or 200 mg twice daily....
Aiza-Haddad, I;
Ballesteros-Amozurrutia, A;
Borjas-Almaguer, OD;
Castillo-Barradas, M;
Castro-Narro, G;
Chávez-Tapia, N;
Chirino-Sprung, RA;
Cisneros-Garza, L;
Dehesa-Violante, M;
Flores-Calderón, J;
Flores-Gaxiola, A;
García-Juárez, I;
González-Huezo, MS;
González-Moreno, EI;
Higuera-de la Tijera, F;
Kershenobich-Stalnikowitz, D;
López-Méndez, E;
Malé-Velázquez, R;
Marín-López, E;
Mata-Marín, JA;
Méndez-Sánchez, N;
Monreal-Robles, R;
Moreno-Alcántar, R;
Muñoz-Espinosa, L;
Navarro-Alvarez, S;
Pavia-Ruz, N;
Pérez-Ríos, AM;
Poo-Ramírez, JL;
Rizo-Robles, MT;
Sánchez-Ávila, JF;
Sandoval-Salas, R;
Torre, A;
Torres-Ibarra, R;
Trejo-Estrada, R;
Velarde-Ruiz Velasco, JA;
Wolpert-Barraza, E;
Bosques-Padilla, F.
El objetivo del Consenso Mexicano para el Tratamiento de la Hepatitis C fue el de desarrollar un documento como guía en la práctica clínica con aplicabilidad en México. Se tomó en cuenta la opinión de expertos en el tema con especialidad en: gastroenterología, infectología y hepatología. Se real...
Zaninotto, G;
Bennett, C;
Boeckxstaens, G;
Costantini, M;
Ferguson, MK;
Pandolfino, JE;
Patti, MG;
Ribeiro Jr, U;
Richter, J;
Swanstrom, L;
Tack, J;
Triadafilopoulos, G;
Markar, SR;
Salvador, R;
Faccio, L;
Andreollo, NA;
Cecconello, I;
Costamagna, G;
da Rocha, JRM;
Hungness, ES;
Fisichella, PM;
Fuchs, KH;
Gockel, I;
Gurski, R;
Gyawali, CP;
Herbella, FAM;
Holloway, RH;
Hongo, M;
Jobe, BA;
Kahrilas, PJ;
Katzka, DA;
Dua, KS;
Liu, D;
Moonen, A;
Nasi, A;
Pasricha, PJ;
Penagini, R;
Perretta, S;
Sallum, RAA;
Sarnelli, G;
Savarino, E;
Schlottmann, F;
Sifrim, D;
Soper, N;
Tatum, RP;
Vaezi, MF;
van Herwaarden-Lindeboom, M;
Vanuytsel, T;
Vela, MF;
Watson, DI;
Zerbib, F;
Gittens, S;
Pontillo, C;
Vermigli, S;
Inama, D;
Low, DE.
Achalasia is a relatively rare primary motor esophageal disorder, characterized by absence of relaxations of the lower esophageal sphincter and of peristalsis along the esophageal body. As a result, patients typically present with dysphagia, regurgitation and occasionally chest pain, pulmonary complicati...
